Key result
Subdiaphragmatic vagal nerve stimulation attenuates age-dependent blood pressure increases versus sham in hypertensive rats.
Why the study?
Does subdiaphragmatic vagal nerve stimulation attenuate the development of hypertension in spontaneously hypertensive rats?
Does subdiaphragmatic vagal nerve stimulation attenuate the development of hypertension in spontaneously hypertensive rats?
Subdiaphragmatic vagal nerve stimulation for 30 minutes daily shows potential as a treatment for hypertension by attenuating its development in a rat model.
Answers are grounded in this paper and cite their sources.
Attenuates hypertension progression in rats; leaves open translation to human therapy.
Augmented vagal signaling may be therapeutic in hypertension. Most studies to date have used stimulation of the cervical vagal branches. Here, we investigated the effects of chronic intermittent electric stimulation of the ventral subdiaphragmatic vagal nerve branch (sdVNS) on long-term blood pressure, immune markers, and gut microbiota in the spontaneously hypertensive rat (SHR), a rodent model of hypertension characterized by vagal dysfunction, gut dysbiosis, and low-grade inflammation. We evaluated the effects of sdVNS on transcriptional networks in the nucleus of the solitary tract (NTS), a major cardioregulatory brain region with direct gut vagal projections. Male juvenile SHRs were implanted with radiotelemetry transmitters and vagal nerve cuffs for chronic intermittent electric sdVNS, applied three times per day for 7 consecutive weeks followed by 1 wk of no stimulation. Blood pressure was measured once a week using telemetry in the sdVNS group as well as age-matched sham-stimulated SHR controls. At the endpoint, colonic and circulating inflammatory markers, corticosterone, and circulating catecholamines were investigated. Bacterial 16 s sequencing measured gut bacterial abundance and composition. RNA sequencing evaluated the effects of sdVNS on transcriptional networks in the NTS. SHRs that received sdVNS exhibited attenuated development of hypertension compared with sham animals. No changes in peripheral inflammatory markers, corticosterone, or catecholamines and no major differences in gut bacterial diversity and composition were observed following sdVNS, apart from decreased abundance of Defluviitaleaceale bacterium detected in sdVNS SHRs compared with sham animals. RNA sequencing revealed significant sdVNS-dependent modulation of select NTS transcriptional networks, including catecholaminergic and corticosteroid networks.NEW & NOTEWORTHY We show that stimulation of the ventral subdiaphragmatic vagal nerve branch may be a promising potential approach to treating hypertension. The data are especially encouraging given that rodents received only 30 min per day of intermittent stimulation therapy and in view of the potential of long-term blood pressure effects that are not stimulus-locked.
No takes yet. Share an insight, caveat, or question.
Dirr et al. (2023) studied Hypertension (n=10). Chronic intermittent electrical stimulation of the ventral subdiaphragmatic vagal nerve branch (sdVNS) vs. Sham stimulation (empty silicone cuff) was evaluated on Change in blood pressure (SBP, DBP, MBP) from baseline over 8 weeks (p=<0.05). Chronic intermittent subdiaphragmatic vagal nerve stimulation significantly attenuated the age-dependent increase in blood pressure in spontaneously hypertensive rats compared to sham (P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: